Talazoparib in Patients with a Germline
            BRCA
            ‐Mutated Advanced Breast Cancer: Detailed Safety Analyses from the Phase III EMBRACA Trial

User: Guest

Title:: Talazoparib in Patients with a Germline BRCA ‐Mutated Advanced Breast Cancer: Detailed Safety Analyses from the Phase III EMBRACA Trial
Document type:: Zeitschriftenaufsatz
Author(s):: Hurvitz, Sara A.; Gonçalves, Anthony; Rugo, Hope S.; Lee, Kyung‐Hun; Fehrenbacher, Louis; Mina, Lida A.; Diab, Sami; Blum, Joanne L.; Chakrabarti, Jayeta; Elmeliegy, Mohamed; DeAnnuntis, Liza; Gauthier, Eric; Czibere, Akos; Tudor, Iulia Cristina; Quek, Ruben G.W.; Litton, Jennifer K.; Ettl, Johannes
Journal title:: The Oncologist
Year:: 2019
Journal volume:: 25
Journal issue:: 3
Fulltext / DOI:: doi:10.1634/theoncologist.2019-0493
Publisher:: Alphamed Press
E-ISSN:: 1083-71591549-490X
Date of publication:: 25.11.2019
BibTeX

Occurrences: